期刊
NATURE NANOTECHNOLOGY
卷 8, 期 10, 页码 735-741出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nnano.2013.194
关键词
-
资金
- National Institutes of Health (NIH) Director's New Innovator Award [1DP2OD006672-01]
- Career Development Program of the Gastrointestinal Specialized Program of Research Excellence (GI SPORE) award [CA130810]
- 3M non-tenured Faculty Award
- National Science Foundation
The spread of cancer throughout the body is driven by circulating tumour cells (CTCs)(1). These cells detach from the primary tumour and move from the bloodstream to a new site of subsequent tumour growth. They also carry information about the primary tumour and have the potential to be valuable biomarkers for disease diagnosis and progression, and for the molecular characterization of certain biological properties of the tumour. However, the limited sensitivity and specificity of current methods for measuring and studying these cells in patient blood samples prevents the realization of their full clinical potential. The use of microfluidic devices is a promising method for isolating CTCs2,3. However, the devices are reliant on three-dimensional structures, which limits further characterization and expansion of cells on the chip. Here we demonstrate an effective approach to isolating CTCs from blood samples of pancreatic, breast and lung cancer patients, by using functionalized graphene oxide nanosheets on a patterned gold surface. CTCs were captured with high sensitivity at a low concentration of target cells (73 +/- 32.4% at 3-5 cells per ml blood).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据